Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00016666Phase 2Completed
Phase 2, randomised, double-blind trial of propranolol in Seasonal Affective Disorder (SAD) (2 arms), sponsored by National Institute of Mental Health. Primary endpoint: Improvement in depressive symptoms at 4 weeks. Started May 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00016666.